logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Koji Izutsu

University of Salamanca

52H指数
615论文数
1.2W被引数
收录论文 107
发表时间
logo
Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphoma利萨库特根马拉鲁塞尔与外部对照臂在第三线或更晚复发或难治性滤泡性淋巴瘤中的比较结果
errLEUKEMIA & LYMPHOMA
IF2.2
err2026-06-07
err0
errOAAI
errNastoupil, Loretta Jo; Martin Garcia-Sancho, Alejandro; Izutsu, Koji; Cartron, Guillaume; Zausner Skarbnik, Alan Pierre; Reguera Ortega, Juan Luis; Goto, Hideki; Borchmann, Peter; Farazi, Thalia; Bar, Merav; del Rosario Olivera, Maria; Kumar, Jinender; De Benedetti, Marc; Gu, Fangyi; Stein, Dara; Han, Jenny; Palomba, Maria Lia
err分享
err收藏
Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORMTRANSFORM研究中lisocabtagene maraleucel在二线治疗大B细胞淋巴瘤中的长期生存情况
errBlood Advances
IF7.1
err2026-05-01
err0
PREAI
errKamdar, Manali; Solomon, Scott R.; Arnason, Jon; Johnston, Patrick B.; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Ribrag, Vincent; Lin, Yi; Bhatnagar, Rashmi; Braun, Robert; Montheard, Sandrine; Abramson, Jeremy S.
err分享
err收藏
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial帕尔托 Brutinib 在复发或难治性华氏巨球蛋白血症患者中的安全性和活性：开放标签、多中心、I/II 期 BRUIN 试验的 5 年随访
errThe Lancet Haematology
IF0
err2026-04-30
err0
PREAI
errM Lia Palomba; Manish R Patel; Toby A Eyre; Wojciech Jurczak; David Lewis; Thomas Gastinne; Shuo Ma; Jonathon B Cohen; Krish Patel; Jennifer R Brown; Lydia Scarfò; Talha Munir; Ewa Lech-Maranda; Marc S Hoffmann; Chaitra S Ujjani; Bita Fakhri; Michael L Wang; Koji Izutsu; Hirokazu Nagai; Constantine S Tam
err分享
err收藏
Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphomaCD5阳性弥漫大B细胞淋巴瘤患者诊断至治疗间隔对其生存的影响
errAnnals of Hematology
IF2.4
err2026-04-25
err0
errOAAI
errYuma Nato; Kana Miyazaki; Dai Maruyama; Hiroyuki Takahashi; Kazutaka Sunami; Eiju Negoro; Satsuki Murakami; Takahiro Okada; Nobuyuki Takayama; Yuri Miyazawa; Ilseung Choi; Shuji Momose; Yuto Kaneda; Masahiro Yoshida; Naoto Tomita; Tohru Murayama; Momoko Nishikori; Junji Hiraga; Kohtaro Toyama; Naoki Takahashi; Taro Masunari; Jun Takizawa; Isao Tawara; Naoko Asano; Koichi Ohshima; Koji Izutsu; Koji Kato; Ritsuro Suzuki; Motoko Yamaguchi
err分享
err收藏
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma嵌合抗原受体T细胞疗法联合帕博利珠单抗作为维持和/或桥接疗法在复发/难治性原发纵隔大B细胞淋巴瘤中的真实世界疗效
errInternational Journal of Clinical Oncology
IF2.8
err2026-04-13
err0
PREAI
errRisa Nishiyama; Shinichi Makita; Anna Hiratsuka; Akiko Miyagi Maeshima; Kimiteru Ito; Yu Aruga; Chiaki Ikeda; Hirotaka Matsui; Wataru Takeda; Mai Takeuchi; Tetsuro Ochi; Noriko Iwaki; Suguru Fukuhara; Wataru Munakata; Koji Izutsu
err分享
err收藏
Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies基因融合检测算法的比较揭示了血液恶性肿瘤中常被忽视的驱动融合。
errnpj Precision Oncology
IF8
err2026-04-04
err0
errOAAI
errZen Tamura; Yuki Saito; Yasunori Kogure; Yuji Oshikawa-Kumade; Suguru Fukuhara; Sumito Shingaki; Hirokazu Kariyazono; Yoshiya Kikukawa; Yuta Ito; Kota Mizuno; Yuichi Shiraishi; Kotoe Katayama; Seiya Imoto; Koji Izutsu; Koichi Murakami; Junji Koya; Keisuke Kataoka
err分享
err收藏
Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system一例液体超负荷相关的大B细胞淋巴瘤（由中枢神经系统原发性大B细胞淋巴瘤演变而来）的克隆分析
errAnnals of Hematology
IF2.4
err2026-03-11
err0
errOAAI
errYuta Ito; Yasunori Kogure; Akiko Miyagi Maeshima; Rika Hosoba; Suguru Fukuhara; Wataru Munakata; Kenichi Chiba; Ai Okada; Yuichi Shiraishi; Yoshitaka Narita; Koji Izutsu; Keisuke Kataoka
err分享
err收藏
Differential Expression of CD79B, CD19, and PD-L1 in de Novo and Transformed CD20-Negative Large B-Cell LymphomasCD79B、CD19和PD-L1在原发性和转化型CD20阴性大型B细胞淋巴瘤中的差异表达
errHematological Oncology
IF3.9
err2026-02-13
err0
PREAI
errYuto Kaimi; Yuka Takahashi; Mai Takeuchi; Tetsuro Ochi; Shinichi Makita; Noriko Iwaki; Suguru Fukuhara; Wataru Munakata; Koji Izutsu; Yasushi Yatabe; Akiko Miyagi Maeshima
err分享
err收藏
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study利萨库特根马拉鲁塞尔在复发或难治性边缘区淋巴瘤患者中的应用（TRANSCEND FL）：一项全球、多队列、单臂、II期研究的主要分析结果
errThe Lancet
IF97.3
err2026-02-12
err0
PREAI
errM Lia Palomba; Stephen J Schuster; Reem Karmali; Alan P Skarbnik; Jeremy S Abramson; Kirit Ardeshna; Peter Borchmann; Brian T Hill; Alejandro Martin García-Sancho; Gianpaolo Marcacci; Aaron P Rapoport; Guillaume Cartron; Isabelle Fleury; Koji Izutsu; Manali Kamdar; Stephan Mielke; Anna Maria Barbui; Juan Luis Reguera Ortega; Loretta J Nastoupil; Sairah Ahmed
err分享
err收藏
Tafasitamab as Monotherapy or in Combination in Japanese Patients With B-Cell Non-Hodgkin Lymphoma: Results From the Phase 1b J-MIND StudyTafasitamab作为单药治疗或联合治疗在日本B细胞非霍奇金淋巴瘤患者中的应用：J-MIND 1b期研究的结果
errCancer Science
IF4.3
err2026-01-21
err0
errOAAI
errKoji Izutsu; Noriko Fukuhara; Junichiro Yuda; Youko Suehiro; Shigeru Kusumoto; Marie-Laure Casadebaig; Kazumi Suzukawa; Kentaro Fukushima
err分享
err收藏
Consideration of the natural history of BCL2-positive follicular lymphoma: based on tumor site, histological grade, and histological transformation rate
errHuman Pathology
IF2.6
err2026-01-13
err0
PREAI
errAkiko Miyagi Maeshima; Yuto Kaimi; Yuka Takahashi; Tetsuro Ochi; Shinichi Makita; Noriko Iwaki; Suguru Fukuhara; Wataru Munakata; Koji Izutsu
err分享
err收藏
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma
errInternational Journal of Clinical Oncology
IF2.8
err2026-01-12
err0
errOAAI
errShinichi Makita; Koji Izutsu; Yuko Mishima; Takahiro Kumode; Junya Kuroda; Nobuhiro Kanemura; Noriko Fukuhara; Kazuyuki Shimada; Chiemi Mori; Atsuko Kawasaki; Takeshi Miyake; Dai Maruyama
err分享
err收藏
Real-world effectiveness and safety of lisocabtagene maraleucel for relapsed/refractory large B cell lymphoma in Japan
errInternational Journal of Clinical Oncology
IF2.8
err2026-01-08
err0
PREAI
errTetsuro Ochi; Shinichi Makita; Anna Hiratsuka; Risa Nishiyama; Kimiteru Ito; Akiko Miyagi Maeshima; Wataru Takeda; Noriko Iwaki; Suguru Fukuhara; Wataru Munakata; Koji Izutsu
err分享
err收藏
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)POLASTAR研究：Pola-R-CHP在未经治疗的日本DLBCL患者中的多中心初步分析
errINTERNATIONAL JOURNAL OF HEMATOLOGY
IF1.8
err2025-12-01
err0
errOAAI
errSatake, Atsushi; Nagate, Yasuhiro; Miyawaki, Kohta; Fujiwara, Yuki; Ota, Shuichi; Muta, Tsuyoshi; Rai, Shinya; Tsurumi, Hisashi; Suzuki, Ritsuro; Miyake, Takaaki; Goto, Hideki; Fukuhara, Noriko; Sakata-Yanagimoto, Mamiko; Izutsu, Koji; Nishikori, Momoko; Shibayama, Hirohiko; Kumode, Takahiro; Ennishi, Daisuke; Shimose, Takayuki; Inubashiri, Naoki; Matsumura, Itaru; Akashi, Koichi; Kato, Koji
err分享
err收藏
Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025日本皮肤科学会指南：2025年日本原发性皮肤淋巴瘤管理指南概述
errThe Journal of Dermatology
IF0
err2025-11-07
err0
errOAAI
errToshihisa Hamada; Makoto Sugaya; Takashi Sakaida; Yoji Hirai; Hikari Boki; Takatoshi Shimauchi; Teruyoshi Hisamoto; Eiji Kiyohara; Kazuyasu Fujii; Ko Sunagawa; Saeko Ozaki; Kayoko Ohnishi; Koji Izutsu; Souichi Shiratori; Ryo Amagai; Kentaro Yonekura; Masashi Iwata; Tomomitsu Miyagaki; Hiroshi Koga; Hiroshi Uchi; Yasuhiro Nakamura
err分享
err收藏
Efficacy and safety of fixed-duration venetoclax plus obinutuzumab in untreated Japanese CLL and SLL: a phase 2 study固定疗程维奈克拉联合奥比妥珠单抗在未经治疗的日本CLL和SLL患者中的疗效与安全性：一项2期研究
errINTERNATIONAL JOURNAL OF HEMATOLOGY
IF1.8
err2025-11-01
err0
errOAAI
errIzutsu, Koji; Watanabe, Mitsumasa; Toubai, Tomomi; Tsukamoto, Taku; Maruyama, Dai; Kumode, Takahiro; Fukuhara, Noriko; Ogawa, Natsumi; Satomi, Natsuko; Nishimura, Yasuko; Honda, Hideyuki; Chyla, Brenda; Takizawa, Jun
err分享
err收藏
Phase I Study of Rogocekib in Patients with Relapsed or Refractory Hematologic Malignancies罗戈塞克单抗治疗复发或难治性血液系统恶性肿瘤的I期研究
errBlood Advances
IF7.1
err2025-10-10
err0
errOAAI
errHisayuki Yokoyama; Noriko Fukuhara; Koji Ando; Hiroatsu Iida; Takahiro Yamauchi; Suguru Fukuhara; Koji Izutsu; Yasushi Tanoue; Maki Yamamoto; Hirokazu Tozaki; Eiji Takahara; Shingo Shoji; Akio Mizutani; Daisuke Morishita; Robert Oda; Hiroshi Miyake; Noboru Yamamoto
err分享
err收藏
Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma日本复发/难治性套细胞淋巴瘤患者接受venetoclax和ibrutinib治疗的长期结局
errinternational journal of oncology
IF2.8
err2025-09-02
err0
errOAAI
errHideki Goto; Satoshi Ito; Masahiro Kizaki; Masaki Yamaguchi; Noriko Fukuhara; Koji Kato; Toko Saito; Yasuhito Terui; Tomomi Soshin; Natsuko Satomi-Tsushita; Hideyuki Honda; Chen Qian; Koji Izutsu
err分享
err收藏
Correlation with CD79B expression and clinicopathological parameters including cell of origin, CD79A and CD19 expression, and CD79B mutation in diffuse large B-cell lymphoma与CD79B表达及临床病理参数（包括起源细胞、CD79A和CD19表达以及CD79B突变）在弥漫性大B细胞淋巴瘤中的相关性
errHuman Pathology
IF2.6
err2025-06-14
err0
PREAI
errYuto Kaimi; Maki Shibata; Suguru Fukuhara; Yuka Takahashi; Tetsuro Ochi; Shinichi Makita; Noriko Iwaki; Wataru Munakata; Koji Izutsu; Yasushi Yatabe; Akiko Miyagi Maeshima
err分享
err收藏
Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphomaTirabrutinib上市后监测在189例复发/难治性原发性中枢神经系统淋巴瘤患者中的应用
errFUTURE ONCOLOGY
IF2.6
err2025-05-27
err0
errOAAI
errKawasaki, Akira; Matsumoto, Ichiro; Izutsu, Koji; Nishikawa, Ryo
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
O
Olivier Hermine
H 指数: 135 · 论文数: 1.8K
P
Pier Luigi Zinzani
H 指数: 117 · 论文数: 1.8K
Y
Yasushi Yatabe
H 指数: 116 · 论文数: 1.2K
S
Satoru Miyano
H 指数: 113 · 论文数: 1.6K
S
Seishi Ogawa
H 指数: 113 · 论文数: 1.5K
查看更多